Global Duchenne Muscular Dystrophy Drugs Market Research Report 2018

Publisher Name :
Date: 07-Aug-2018
No. of pages: 110
Inquire Before Buying

This report studies the global Duchenne Muscular Dystrophy Drugs market status and forecast, categorizes the global Duchenne Muscular Dystrophy Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death.

The main symptoms of this condition appears in childhood and includes delay of motor functions; progressive muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in the lower half of the body. The bones also develop peculiarly, causing skeletal deformities in the patient.  Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other symptoms of this condition.

The global Duchenne Muscular Dystrophy Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

- Akashi Therapeutics Inc

- Antisense Therapeutics Ltd

- Beech Tree Labs Inc

- Biogen Inc

- Bioleaders Corp

- BioMarin Pharmaceutical Inc

- Biophytis SAS

- Capricor Therapeutics Inc

- Catabasis Pharmaceuticals Inc

- CRISPR Therapeutics

- Cumberland Pharmaceuticals Inc

- Daiichi Sankyo Co Ltd

- Debiopharm International SA

- Editas Medicine Inc

- Eloxx Pharmaceuticals Inc

- F. Hoffmann-La Roche Ltd

- FibroGen Inc

- Fulcrum Therapeutics Inc

- Galapagos NV

- Genethon SA

- GTx Inc

- Santhera Pharmaceuticals Holding AG

- Sarepta Therapeutics Inc

- SOM Biotech SL

- Strykagen Corp

- Summit Therapeutics Plc

- Taiho Pharmaceutical Co Ltd

- Teijin Pharma Ltd

- WAVE Life Sciences Ltd

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Development & Drug Target

- Mechanism of Action (MoA)

- Route of Administration (RoA)

- Molecule Type

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Hospitals and Clinics

- Medical Laboratories

- Others

The study objectives of this report are:

- To analyze and study the global Duchenne Muscular Dystrophy Drugs sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Duchenne Muscular Dystrophy Drugs manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Duchenne Muscular Dystrophy Drugs are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Duchenne Muscular Dystrophy Drugs Manufacturers

Duchenne Muscular Dystrophy Drugs Distributors/Traders/Wholesalers

Duchenne Muscular Dystrophy Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Duchenne Muscular Dystrophy Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Duchenne Muscular Dystrophy Drugs Market Research Report 2018

Table of Contents
Global Duchenne Muscular Dystrophy Drugs Market Research Report 2018
1 Duchenne Muscular Dystrophy Drugs Market Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Drugs
1.2 Duchenne Muscular Dystrophy Drugs Segment by Type (Product Category)
1.2.1 Global Duchenne Muscular Dystrophy Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Duchenne Muscular Dystrophy Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Development & Drug Target
1.2.4 Mechanism of Action (MoA)
1.2.5 Route of Administration (RoA)
1.2.6 Molecule Type
1.3 Global Duchenne Muscular Dystrophy Drugs Segment by Application
1.3.1 Duchenne Muscular Dystrophy Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals and Clinics
1.3.3 Medical Laboratories
1.3.4 Others
1.4 Global Duchenne Muscular Dystrophy Drugs Market by Region (2013-2025)
1.4.1 Global Duchenne Muscular Dystrophy Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Duchenne Muscular Dystrophy Drugs (2013-2025)
1.5.1 Global Duchenne Muscular Dystrophy Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Duchenne Muscular Dystrophy Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Duchenne Muscular Dystrophy Drugs Market Competition by Manufacturers
2.1 Global Duchenne Muscular Dystrophy Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Duchenne Muscular Dystrophy Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Duchenne Muscular Dystrophy Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Duchenne Muscular Dystrophy Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Duchenne Muscular Dystrophy Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Duchenne Muscular Dystrophy Drugs Market Competitive Situation and Trends
2.5.1 Duchenne Muscular Dystrophy Drugs Market Concentration Rate
2.5.2 Duchenne Muscular Dystrophy Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Duchenne Muscular Dystrophy Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Duchenne Muscular Dystrophy Drugs Production and Market Share by Region (2013-2018)
3.3 Global Duchenne Muscular Dystrophy Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Duchenne Muscular Dystrophy Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Duchenne Muscular Dystrophy Drugs Consumption by Region (2013-2018)
4.2 North America Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Duchenne Muscular Dystrophy Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Duchenne Muscular Dystrophy Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Duchenne Muscular Dystrophy Drugs Production and Market Share by Type (2013-2018)
5.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Duchenne Muscular Dystrophy Drugs Price by Type (2013-2018)
5.4 Global Duchenne Muscular Dystrophy Drugs Production Growth by Type (2013-2018)
6 Global Duchenne Muscular Dystrophy Drugs Market Analysis by Application
6.1 Global Duchenne Muscular Dystrophy Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Duchenne Muscular Dystrophy Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Duchenne Muscular Dystrophy Drugs Manufacturers Profiles/Analysis
7.1 Akashi Therapeutics Inc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Antisense Therapeutics Ltd
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Beech Tree Labs Inc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Biogen Inc
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Biogen Inc Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Bioleaders Corp
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 BioMarin Pharmaceutical Inc
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Biophytis SAS
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Biophytis SAS Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Capricor Therapeutics Inc
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Catabasis Pharmaceuticals Inc
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 CRISPR Therapeutics
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Duchenne Muscular Dystrophy Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Cumberland Pharmaceuticals Inc
7.12 Daiichi Sankyo Co Ltd
7.13 Debiopharm International SA
7.14 Editas Medicine Inc
7.15 Eloxx Pharmaceuticals Inc
7.16 F. Hoffmann-La Roche Ltd
7.17 FibroGen Inc
7.18 Fulcrum Therapeutics Inc
7.19 Galapagos NV
7.20 Genethon SA
7.21 GTx Inc
7.22 Santhera Pharmaceuticals Holding AG
7.23 Sarepta Therapeutics Inc
7.24 SOM Biotech SL
7.25 Strykagen Corp
7.26 Summit Therapeutics Plc
7.27 Taiho Pharmaceutical Co Ltd
7.28 Teijin Pharma Ltd
7.29 WAVE Life Sciences Ltd
8 Duchenne Muscular Dystrophy Drugs Manufacturing Cost Analysis
8.1 Duchenne Muscular Dystrophy Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Duchenne Muscular Dystrophy Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Duchenne Muscular Dystrophy Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Duchenne Muscular Dystrophy Drugs Market Forecast (2018-2025)
12.1 Global Duchenne Muscular Dystrophy Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Duchenne Muscular Dystrophy Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Duchenne Muscular Dystrophy Drugs Price and Trend Forecast (2018-2025)
12.2 Global Duchenne Muscular Dystrophy Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Duchenne Muscular Dystrophy Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Duchenne Muscular Dystrophy Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Duchenne Muscular Dystrophy Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Duchenne Muscular Dystrophy Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Duchenne Muscular Dystrophy Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Duchenne Muscular Dystrophy Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Duchenne Muscular Dystrophy Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Duchenne Muscular Dystrophy Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Duchenne Muscular Dystrophy Drugs
Figure Global Duchenne Muscular Dystrophy Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Development & Drug Target
Table Major Manufacturers of Development & Drug Target
Figure Product Picture of Mechanism of Action (MoA)
Table Major Manufacturers of Mechanism of Action (MoA)
Figure Product Picture of Route of Administration (RoA)
Table Major Manufacturers of Route of Administration (RoA)
Figure Product Picture of Molecule Type
Table Major Manufacturers of Molecule Type
Figure Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) by Applications (2013-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Applications in 2017
Figure Hospitals and Clinics Examples
Table Key Downstream Customer in Hospitals and Clinics
Figure Medical Laboratories Examples
Table Key Downstream Customer in Medical Laboratories
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Duchenne Muscular Dystrophy Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Major Players Product Capacity (K Units) (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Duchenne Muscular Dystrophy Drugs Capacity (K Units) of Key Manufacturers in 2018
Figure Global Duchenne Muscular Dystrophy Drugs Major Players Product Production (K Units) (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Production (K Units) of Key Manufacturers (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Duchenne Muscular Dystrophy Drugs Production Share by Manufacturers
Figure 2017 Duchenne Muscular Dystrophy Drugs Production Share by Manufacturers
Figure Global Duchenne Muscular Dystrophy Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Duchenne Muscular Dystrophy Drugs Revenue Share by Manufacturers
Table 2018 Global Duchenne Muscular Dystrophy Drugs Revenue Share by Manufacturers
Table Global Market Duchenne Muscular Dystrophy Drugs Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Duchenne Muscular Dystrophy Drugs Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Duchenne Muscular Dystrophy Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Duchenne Muscular Dystrophy Drugs Product Category
Figure Duchenne Muscular Dystrophy Drugs Market Share of Top 3 Manufacturers
Figure Duchenne Muscular Dystrophy Drugs Market Share of Top 5 Manufacturers
Table Global Duchenne Muscular Dystrophy Drugs Capacity (K Units) by Region (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Capacity Market Share by Region (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Duchenne Muscular Dystrophy Drugs Capacity Market Share by Region
Table Global Duchenne Muscular Dystrophy Drugs Production by Region (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Production (K Units) by Region (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Duchenne Muscular Dystrophy Drugs Production Market Share by Region
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Region (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Region
Figure Global Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) Market by Region (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Region (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) Market Share by Region
Table North America Duchenne Muscular Dystrophy Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Duchenne Muscular Dystrophy Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Duchenne Muscular Dystrophy Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Duchenne Muscular Dystrophy Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Duchenne Muscular Dystrophy Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Duchenne Muscular Dystrophy Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Production (K Units) by Type (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Duchenne Muscular Dystrophy Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Duchenne Muscular Dystrophy Drugs by Type
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Duchenne Muscular Dystrophy Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Duchenne Muscular Dystrophy Drugs by Type
Table Global Duchenne Muscular Dystrophy Drugs Price (USD/Unit) by Type (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Production Growth by Type (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) by Application (2013-2018)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Application (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Application in 2017
Table Global Duchenne Muscular Dystrophy Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Growth Rate by Application (2013-2018)
Table Akashi Therapeutics Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (Akashi Therapeutics Inc) and Gross Margin (2013-2018)
Figure Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Antisense Therapeutics Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Beech Tree Labs Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Biogen Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Inc Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Inc Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Biogen Inc Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Biogen Inc Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Bioleaders Corp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bioleaders Corp Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bioleaders Corp Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Bioleaders Corp Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Bioleaders Corp Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table BioMarin Pharmaceutical Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Biophytis SAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biophytis SAS Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biophytis SAS Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Biophytis SAS Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Biophytis SAS Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Capricor Therapeutics Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Catabasis Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table CRISPR Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Production Growth Rate (2013-2018)
Figure CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Production Market Share (2013-2018)
Figure CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Duchenne Muscular Dystrophy Drugs
Figure Manufacturing Process Analysis of Duchenne Muscular Dystrophy Drugs
Figure Duchenne Muscular Dystrophy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Duchenne Muscular Dystrophy Drugs Major Manufacturers in 2017
Table Major Buyers of Duchenne Muscular Dystrophy Drugs
Table Distributors/Traders List
Figure Global Duchenne Muscular Dystrophy Drugs Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Duchenne Muscular Dystrophy Drugs Production (K Units) Forecast by Region (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Duchenne Muscular Dystrophy Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Duchenne Muscular Dystrophy Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Duchenne Muscular Dystrophy Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Duchenne Muscular Dystrophy Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Duchenne Muscular Dystrophy Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Duchenne Muscular Dystrophy Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Duchenne Muscular Dystrophy Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Duchenne Muscular Dystrophy Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Duchenne Muscular Dystrophy Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Duchenne Muscular Dystrophy Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Duchenne Muscular Dystrophy Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Duchenne Muscular Dystrophy Drugs Production (K Units) Forecast by Type (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Production (K Units) Forecast by Type (2018-2025)
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Duchenne Muscular Dystrophy Drugs Price Forecast by Type (2018-2025)
Table Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Global Testosterone Replacement Therapy Market Professional Survey Report 2018
    Published: 19-Jul-2018        Price: US 3500 Onwards        Pages: 111
    This report studies the global Testosterone Replacement Therapy market status and forecast, categorizes the global Testosterone Replacement Therapy market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Testosterone replacement therapy (TRT) is a class of hormone replacement therapy ......
  • Erectile Dysfunction - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 118
    Erectile Dysfunction - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2018, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include tobacc......
  • Male Hypogonadism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 101
    Male Hypogonadism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Male Hypogonadism - Pipeline Review, H2 2018, provides an overview of the Male Hypogonadism (Male Health) pipeline landscape. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosi......
  • Global and United States Erectile Dysfunction(ED) Drug Market Research by Company, Type & Application 2013-2025
    Published: 15-Jul-2018        Price: US 2000 Onwards        Pages: 98
    Summary Market Segment as follows: By Type - Vardenafil - Avanafil - Tadalafil - Vardenafil By Application - Supermarket - Online Store - Pharmacy - Others By Company - Pfizer - Lilly - Bayer - Johnson & Johnson - Baiyunshan Pharmaceutical Company - Cipla The main contents of the report including: Section 1: Product definition, type and application, g......
  • Global Testosterone Replacement Therapy Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Jul-2018        Price: US 3480 Onwards        Pages: 133
    Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development. Scope of the Report: This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Midd......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Testosterone Replacement Therapy Market 2018, Forecast to 2023
    Published: 10-Jul-2018        Price: US 4880 Onwards        Pages: 135
    Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development. Scope of the Report: This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Midd......
  • Global Erectile Dysfunction Drugs Sales Market Report 2018
    Published: 04-Jul-2018        Price: US 4000 Onwards        Pages: 101
    This report studies the global Erectile Dysfunction Drugs market status and forecast, categorizes the global Erectile Dysfunction Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). The global Erectile Dysfunction Drugs market is valued at million US$ in 2017 and will reach million US$ b......
  • 2018-2023 United States Testosterone Replacement Therapy Market Report (Status and Outlook)
    Published: 27-Jun-2018        Price: US 3360 Onwards        Pages: 89
    In 2017, the Testosterone Replacement Therapy market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - AbbVie - Endo International - Eli lilly - Pfizer - Actavis (Allergan) - Bayer - Novartis - Teva - Mylan - Upsher-Smith - Ferring Pharmaceuticals - Kyowa Kirin - Acerus......
  • 2018-2023 India Testosterone Replacement Therapy Market Report (Status and Outlook)
    Published: 27-Jun-2018        Price: US 3360 Onwards        Pages: 89
    In 2017, the Testosterone Replacement Therapy market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - AbbVie - Endo International - Eli lilly - Pfizer - Actavis (Allergan) - Bayer - Novartis - Teva - Mylan - Upsher-Smith - Ferring Pharmaceuticals - Kyowa Kirin - Acerus Pharmaceuticals......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs